Premium
Arcutis Biotherapeutics Inc (ARQT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Ms. Latha VairavanSenior VP & CFO | -435,00 | 9,16k | Vente | 21,05 | 85,98k | -0,50% |
| 2026-05-11 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -222,00 | 4,67k | Vente | 21,05 | 120,24k | -0,18% |
| 2026-05-04 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -7,37k | 171,54k | Automatic Disposition | 23,27 | 36,75k | -16,71% |
| 2026-05-04 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -884,00 | 20,87k | Vente | 23,61 | 36,75k | -2,35% |
| 2026-05-04 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -684,00 | 16,15k | Vente | 23,61 | 120,47k | -0,56% |
| 2026-05-04 | Ms. Latha VairavanSenior VP & CFO | -1,34k | 31,66k | Vente | 23,61 | 28,20k | -4,54% |
| 2026-05-04 | Mr. Todd Franklin WatanabePresident, CEO & Director | -3,17k | 74,89k | Vente | 23,61 | 625,24k | -0,50% |
| 2026-05-01 | Dr. Howard G. WelgusIndependent Director | -7,14k | 164,22k | Automatic Disposition | 22,99 | 24,99k | -22,23% |
| 2026-04-01 | Dr. Howard G. WelgusIndependent Director | -10,00k | 238,80k | Automatic Disposition | 23,88 | 32,14k | -23,73% |
| 2026-03-02 | Mr. Keith R. LeonardIndependent Chairman of the Board | -39,27k | 671,96k | Derivative Exercise and Sale | 7,51 - 25,39 | 16,26k | - |
| 2026-03-02 | Dr. Howard G. WelgusIndependent Director | -10,00k | 256,52k | Automatic Disposition | 25,65 | 42,14k | -19,18% |
| 2026-03-02 | Mr. Larry Todd EdwardsExec. VP & Chief Commercial Officer | -3,69k | 92,85k | Vente | 25,16 - 25,91 | 55,68k | -6,21% |
| 2026-03-02 | Mr. Todd Franklin WatanabePresident, CEO & Director | -37,35k | 940,53k | Vente | 25,16 - 25,91 | 663,04k | -5,33% |
| 2026-03-02 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -6,29k | 158,32k | Vente | 25,16 - 25,91 | 121,15k | -4,93% |
| 2026-03-02 | Ms. Latha VairavanSenior VP & CFO | -2,85k | 71,84k | Vente | 25,16 - 25,91 | 24,54k | -10,41% |
| 2026-03-02 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -6,75k | 169,88k | Vente | 25,16 - 25,91 | 41,34k | -14,03% |
| 2026-02-27 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -5,31k | 144,00k | Automatic Disposition | 25,70 - 27,95 | 41,34k | -11,39% |
| 2026-02-02 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -7,98k | 203,55k | Vente | 25,50 | 37,66k | -17,49% |
| 2026-02-02 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -32,66k | 823,74k | Automatic Disposition | 24,97 - 25,63 | 37,66k | -46,44% |
| 2026-02-02 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -3,68k | 93,71k | Vente | 25,50 | 80,65k | -4,36% |
| 2026-02-04 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -9,79k | 252,75k | Automatic Disposition | 25,81 | 80,65k | -10,83% |
| 2026-02-02 | Mr. Todd Franklin WatanabePresident, CEO & Director | -19,83k | 505,71k | Vente | 25,50 | 640,77k | -3,00% |
| 2026-02-02 | Ms. Latha VairavanSenior VP & CFO | -1,32k | 33,66k | Vente | 25,50 | 20,33k | -6,10% |
| 2026-02-02 | Dr. Howard G. WelgusIndependent Director | -10,00k | 250,48k | Automatic Disposition | 25,05 | 52,14k | -16,09% |
| 2026-02-02 | Mr. Larry Todd EdwardsExec. VP & Chief Commercial Officer | -2,05k | 52,32k | Vente | 25,50 | 49,87k | -3,95% |
| 2026-01-05 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -2,49k | 72,17k | Automatic Disposition | 28,98 | 94,12k | -2,58% |
| 2026-01-02 | Dr. Howard G. WelgusIndependent Director | -10,00k | 289,61k | Automatic Disposition | 28,96 | 62,14k | -13,86% |
| 2025-12-31 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -1,70k | 49,56k | Vente | 28,81 - 29,39 | 96,61k | -1,73% |
| 2025-12-15 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -11,50k | 290,99k | Derivative Exercise and Sale | 3,64 - 28,94 | 98,31k | - |
| 2025-12-01 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -1,66k | 50,09k | Automatic Disposition | 30,23 | 57,52k | -2,80% |
| 2025-12-01 | Dr. Howard G. WelgusIndependent Director | -10,00k | 302,13k | Automatic Disposition | 30,21 | 72,14k | -12,18% |
| 2025-11-24 | Ms. Sue-Jean LinIndependent Director | -25,27k | 567,94k | Derivative Exercise and Sale | 7,51 - 30,78 | 19,13k | - |
| 2025-11-21 | Mr. Todd Franklin WatanabePresident, CEO & Director | -50,00k | 1,52M | Automatic Disposition | 30,00 - 30,36 | 603,18k | -7,65% |
| 2025-11-19 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -2,55k | 72,14k | Vente | 27,95 - 28,50 | 58,35k | -4,19% |
| 2025-11-20 | Dr. Halley E. GilbertIndependent Director | -12,22k | 244,88k | Derivative Exercise and Sale | 7,51 - 27,55 | 14,51k | - |
| 2025-11-20 | Dr. Halley E. GilbertIndependent Director | -4,31k | 118,79k | Vente | 27,55 | 14,51k | -22,90% |
| 2025-11-13 | Ms. Neha KrishnamohanIndependent Director | -39,27k | 585,47k | Derivative Exercise and Sale | 7,51 - 23,19 | 14,51k | - |
| 2025-11-13 | Ms. Neha KrishnamohanIndependent Director | -1,23k | 28,79k | Automatic Disposition | 23,37 | 14,51k | -7,82% |
| 2025-11-13 | Mr. Keith R. LeonardIndependent Chairman of the Board | -4,31k | 0,00 | Other Disposition | - | 16,26k | -20,96% |
| 2025-11-06 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -17,25k | 354,35k | Derivative Exercise and Sale | 3,64 - 24,18 | 98,33k | - |
| 2025-11-06 | Mr. Larry Todd EdwardsExec. VP & Chief Commercial Officer | -29,13k | 732,93k | Vente | 25,16 | 44,19k | -39,73% |
| 2025-11-03 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -2,62k | 64,81k | Vente | 24,71 - 25,40 | 98,33k | -2,60% |
| 2025-11-05 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -3,86k | 91,64k | Automatic Disposition | 23,72 | 98,33k | -3,78% |
| 2025-11-03 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -7,21k | 178,16k | Vente | 24,71 - 25,40 | 59,68k | -10,78% |
| 2025-11-03 | Mr. Todd Franklin WatanabePresident, CEO & Director | -11,55k | 285,40k | Vente | 24,71 - 25,40 | 657,54k | -1,73% |
| 2025-11-03 | Ms. Latha VairavanSenior VP & CFO | -88,00 | 2,18k | Vente | 24,72 | 18,54k | -0,47% |
| 2025-11-03 | Dr. Howard G. WelgusIndependent Director | -10,00k | 252,67k | Automatic Disposition | 25,27 | 82,14k | -10,85% |
| 2025-10-28 | Mr. Todd Franklin WatanabePresident, CEO & Director | -40,00k | 1,00M | Automatic Disposition | 25,03 | 643,52k | -5,85% |
| 2025-10-02 | Mr. Larry Todd EdwardsExec. VP & Chief Commercial Officer | -4,50k | 90,26k | Vente | 19,99 - 20,78 | 73,32k | -5,79% |
| 2025-10-01 | Mr. Todd Franklin WatanabePresident, CEO & Director | -45,00k | 884,65k | Automatic Disposition | 18,91 - 20,04 | 683,52k | -6,18% |
| 2025-10-01 | Dr. Howard G. WelgusIndependent Director | -9,54k | 164,46k | Derivative Exercise and Sale | 1,68 - 18,92 | 92,14k | - |
| 2025-10-01 | Dr. Howard G. WelgusIndependent Director | -462,00 | 8,74k | Automatic Disposition | 18,92 | 92,14k | -0,50% |
| 2025-09-08 | Mr. Todd Franklin WatanabePresident, CEO & Director | -10,13k | 177,63k | Automatic Disposition | 17,52 - 17,54 | 728,52k | -1,37% |
| 2025-09-04 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -36,13k | 583,72k | Automatic Disposition | 16,16 | 53,11k | -40,49% |
| 2025-09-02 | Dr. Howard G. WelgusIndependent Director | -10,00k | 156,38k | Derivative Exercise and Sale | 15,64 | 92,60k | - |
| 2025-08-19 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -1,75k | 28,28k | Vente | 16,16 | 104,81k | -1,64% |
| 2025-08-21 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -2,44k | 37,97k | Automatic Disposition | 15,57 | 104,81k | -2,27% |
| 2025-08-08 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -3,85k | 53,99k | Automatic Disposition | 14,03 | 109,00k | -3,41% |
| 2025-08-04 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -2,62k | 37,56k | Vente | 14,33 | 112,85k | -2,27% |
| 2025-08-04 | Ms. Latha VairavanSenior VP & CFO | -89,00 | 1,28k | Vente | 14,33 | 18,39k | -0,48% |
| 2025-08-01 | Dr. Howard G. WelgusIndependent Director | -10,00k | 142,98k | Derivative Exercise and Sale | 14,30 | 92,60k | - |
| 2025-08-04 | Mr. Todd Franklin WatanabePresident, CEO & Director | -11,55k | 165,43k | Vente | 14,33 | 738,65k | -1,54% |
| 2025-08-04 | Mr. Masaru MatsudaExec. VP, Chief Legal Officer & Corporate Secretary | -6,33k | 90,69k | Vente | 14,33 | 89,24k | -6,62% |
| 2025-07-10 | Dr. Patrick E. BurnettExec. VP & Chief Medical Officer | -28,75k | 432,70k | Derivative Exercise and Sale | 15,05 - 15,07 | 115,47k | - |
| 2025-07-01 | Dr. Howard G. WelgusIndependent Director | -9,21k | 127,43k | Automatic Disposition | 13,84 | 92,60k | -9,04% |
| 2025-06-18 | Dr. Howard G. WelgusIndependent Director | -10,14k | 135,57k | Automatic Disposition | 13,37 | 101,81k | -9,06% |
| 2025-06-13 | Frazier Life Sciences Management, LPSociété | 2,65k | 34,61k | Achat | 13,08 | 8,81M | 0,03% |
| 2025-06-10 | Mr. Todd Franklin WatanabePresident, CEO & Director | -1,99k | 0,00 | Other Disposition | - | 724,63k | -0,27% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
